VEA
RGNX icon

Virtus ETF Advisers’s Regenxbio RGNX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-8,153
Closed -$63K 586
2024
Q4
$63K Buy
8,153
+1,110
+16% +$8.58K 0.03% 435
2024
Q3
$73.9K Buy
7,043
+122
+2% +$1.28K 0.03% 420
2024
Q2
$81K Buy
6,921
+2,762
+66% +$32.3K 0.04% 402
2024
Q1
$87.6K Sell
4,159
-288
-6% -$6.07K 0.05% 384
2023
Q4
$79.8K Sell
4,447
-578
-12% -$10.4K 0.05% 417
2023
Q3
$82.7K Sell
5,025
-498
-9% -$8.2K 0.05% 356
2023
Q2
$110K Buy
5,523
+1,266
+30% +$25.3K 0.07% 345
2023
Q1
$80.5K Sell
4,257
-1,636
-28% -$30.9K 0.04% 384
2022
Q4
$134K Buy
5,893
+645
+12% +$14.6K 0.07% 384
2022
Q3
$139K Buy
5,248
+39
+0.7% +$1.03K 0.06% 364
2022
Q2
$129K Buy
5,209
+379
+8% +$9.39K 0.05% 356
2022
Q1
$160K Sell
4,830
-282
-6% -$9.34K 0.07% 217
2021
Q4
$167K Sell
5,112
-548
-10% -$17.9K 0.06% 300
2021
Q3
$237K Sell
5,660
-302
-5% -$12.6K 0.1% 225
2021
Q2
$232K Sell
5,962
-1,516
-20% -$59K 0.1% 238
2021
Q1
$255K Buy
7,478
+139
+2% +$4.74K 0.11% 284
2020
Q4
$333K Sell
7,339
-1,420
-16% -$64.4K 0.14% 184
2020
Q3
$241K Sell
8,759
-1,193
-12% -$32.8K 0.13% 274
2020
Q2
$367K Buy
9,952
+1,716
+21% +$63.3K 0.17% 243
2020
Q1
$267K Sell
8,236
-1,200
-13% -$38.9K 0.11% 244
2019
Q4
$387K Buy
9,436
+4,204
+80% +$172K 0.06% 270
2019
Q3
$186K Sell
5,232
-292
-5% -$10.4K 0.04% 260
2019
Q2
$284K Sell
5,524
-317
-5% -$16.3K 0.06% 240
2019
Q1
$335K Sell
5,841
-681
-10% -$39.1K 0.71% 49
2018
Q4
$274K Sell
6,522
-1,930
-23% -$81.1K 0.05% 140
2018
Q3
$638K Sell
8,452
-6,040
-42% -$456K 0.07% 87
2018
Q2
$1.04M Sell
14,492
-12,068
-45% -$866K 0.92% 8
2018
Q1
$793K Buy
26,560
+14,309
+117% +$427K 0.69% 74
2017
Q4
$407K Sell
12,251
-5,020
-29% -$167K 0.51% 50
2017
Q3
$569K Buy
17,271
+1,580
+10% +$52.1K 0.08% 82
2017
Q2
$310K Buy
+15,691
New +$310K 0.05% 116